Patient Information

CSL Behring UK Ltd is committed to improving the quality of life for patients with rare diseases, including primary immune deficiencies, haemophilia and von Willebrand disease. Our therapies also help prevent blood-related diseases in newborns, and are used in wound healing.

Coagulation
CSL Behring UK Ltd provides a range of therapies to treat coagulation disorders such as haemophilia and von Willebrand disease. Haemophilia is a problem with the blood in which there is not enough of one of the clotting factors needed for blood clots to form. People with von Willebrand Disease (VWD) have a problem with one of the clotting factors in the blood; this particular clotting factor is known as von Willebrand factor (VWF). Please click here for further information.

Immunology
CSL Behring UK Ltd provides a range of therapies to treat immune deficiency disorders. In general, immunodeficiency means that one or more components of the immune system are either absent or function abnormally. Please here for further information.

Haemolytic Disease of the Newborn
Haemolytic Disease of the Newborn (HDN) is caused by an incompatibility between the rhesus blood group of the mother and foetus. CSL Behring UK Ltd provides a product to prevent Haemolytic Disease of the Newborn. Please click here for further information.

Critical Care
CSL Behring UK Ltd also has a critical care product. Please click here for further information.

Glossary
Please click above to access a glossary of terms used on the CSL Behring UK Ltd website.

For further information on the conditions that can be treated by CSL Behring UK Ltd, please click on the links in the left-hand menu bar.

If you wish to order multiple hard copies of the documents within this section please call 01444 447 419 or email us to place your order.